Navigating your path to globalization: Untangling the regulatory maze of the Advanced Therapies supply chain
Discover how Cryoport Systems can help you navigate EMEA regulations and manage the supply chain complexities for advanced therapies.
Sponsored
- Latest Posts
How a microbial expression update is driving biotech innovation
Discover how microbial expression systems are revolutionizing protein production for next-gen therapies like antibodies and peptides.
Overcoming obstacles as advanced therapies continue to evolve in Europe
Discover strategies to overcome the challenges in advanced therapy development in Europe’s evolving biopharmaceutical landscape.
The untapped power of multivariate analysis for target identification in cancer drug discovery
Discover how multivariate analysis is transforming target identification in cancer drug discovery by moving beyond traditional methods.
Powering up biologics development using mammalian cell lines
Explore how mammalian cell lines drive biopharmaceutical innovation, acting as mini-factories for vital biotherapeutics and vaccines.
Cell avidity-tuning ensures safe CAR-T therapy for solid tumors
Learn more about the potential of cell avidity in designing potent and safe CAR-T treatments for solid tumors.
ADVERTISEMENT
ADVERTISEMENT
Biologics testing: The right time to move to new standards?
Discover the challenges facing biologics testing and how modern methods like NGS are revolutionizing quality control, ensuring safety and efficacy.
Complex innovative designs: tackling rare disease clinical trial challenges
Unlock the power of complex innovative designs to tackle rare disease clinical trial challenges efficiently.
Large molecule manufacturing: addressing challenges with strategies for success
Discover the landscape of large molecule manufacturing, exploring challenges, latest innovations, and winning strategies for success.
Protein inhibitors: cracking the code of disease mechanisms
Explore how protein inhibitors revolutionize disease understanding, by unlocking the secrets of disease pathways.
More sustainable drug development and lab sustainability
From reducing carbon footprints to optimising costs, explore innovative solutions for sustainable drug discovery and development!
Why Fina Biosolutions partnered with Scorpius BioManufacturing for cGMP production of EcoCRM® (CRM197)
Explore Fina Biosolutions’ alliance with Scorpius BioManufacturing, driving affordability in global conjugate vaccine production.
ADVERTISEMENT
